Genus plc (LON:GNS)‘s stock had its “hold” rating reiterated by research analysts at Numis Securities Ltd in a research note issued on Thursday. They currently have a GBX 1,815 ($23.44) price target on the stock. Numis Securities Ltd’s target price points to a potential downside of 7.16% from the company’s current price.

Other equities analysts have also recently issued research reports about the company. Liberum Capital reiterated a “buy” rating and set a GBX 1,950 ($25.18) price objective on shares of Genus plc in a report on Monday, September 4th. Peel Hunt reiterated a “buy” rating and set a GBX 2,600 ($33.58) price objective on shares of Genus plc in a report on Monday, September 4th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of GBX 2,121.67 ($27.40).

Genus plc (GNS) traded down 0.41% during trading on Thursday, reaching GBX 1955.00. The company had a trading volume of 24,810 shares. Genus plc has a 52-week low of GBX 1,652.00 and a 52-week high of GBX 2,113.00. The company has a 50 day moving average price of GBX 1,799.65 and a 200 day moving average price of GBX 1,798.37. The company’s market capitalization is GBX 1.19 billion.

Genus plc (LON:GNS) last released its quarterly earnings data on Monday, September 4th. The company reported $0.54 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.65 by $0.11. Genus plc had a net margin of 3.96% and a return on equity of 4.17%. On average, equities analysts forecast that Genus plc will post $64.47 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This article was posted by American Banking News and is the property of of American Banking News. If you are reading this article on another domain, it was stolen and republished in violation of U.S. & international copyright and trademark laws. The original version of this article can be accessed at

About Genus plc

Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.

Analyst Recommendations for Genus plc (LON:GNS)

Receive News & Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related companies with's FREE daily email newsletter.